Velpaget 400/100mg Tablet

Velpaget 400/100mg Tablet is a combination medication containing two active ingredients: Sofosbuvir & Velpatasvir. Sofosbuvir belongs to a class of medications called nucleotide polymerase inhibitors, while Velpatasvir is an inhibitor of the hepatitis C virus (HCV) NS5A protein. This combination is used in the treatment of chronic hepatitis C virus (HCV) infection.

Indications:

Velpaget 400/100mg Tablet is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults. It is effective against HCV genotypes 1, 2, 3, 4, 5, or 6.

Dosage and Administration:

• The recommended dosage of Velpaget 400/100mg Tablet is one tablet taken orally once daily with or without food.
• The duration of treatment may vary depending on the genotype of the hepatitis C virus and the patient’s medical history.
• Prior to initiating treatment, patients should undergo testing to determine the genotype of the hepatitis C virus and assess for other medical conditions.

Precautions:

• Velpaget 400/100mg Tablet should be used with caution in patients with severe renal impairment or end-stage renal disease.
• Careful monitoring of renal function and liver function is recommended during treatment with this medication.
• Co-administration with certain medications may result in drug interactions, so it is essential to review the patient’s medication profile before initiating therapy.

Contraindications:

• Velpaget 400/100mg Tablet is contraindicated in patients with known hypersensitivity to Sofosbuvir, Velpatasvir, or any components of the formulation.

Side Effects:

Common side effects of Velpaget 400/100mg Tablet may include:

• Headache
• Fatigue
• Nausea
• Diarrhea
• Insomnia
• Anemia
• Elevated liver enzymes
• Rash
• Photosensitivity

Storage:

• Store Velpaget 400/100mg Tablet at room temperature (20-25°C) in a dry place away from direct sunlight.
• Keep the tablets in the original container and out of reach of children.